A cutting-edge diagnostic test is helping some doctors find diagnoses for medical mysteries by analyzing DNA and RNA to ...

Concurrent DNA and RNA sequencing revealed 15.3% more patients with actionable variants than DNA sequencing alone.

Tejas Savant’s rating is based on Illumina’s position as a leading player in the next-generation sequencing market, supported by its innovative platform that offers high throughput sequencing at lower ...

The global nucleic acid amplification testing market revenue was around US$ 4.8 billion in 2022 and is estimated to reach US$ 9.1 billion by 2032, growing at a compound annual growth rate (CAGR) of ...

Researchers developed CpGPT, a novel foundation model for DNA methylation analysis that captures sequence, positional, and ...

New real-world data from Providence, Illumina (NASDAQ: ILMN), and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a cancer patient's diagnosis, leads to ...

New real-world data from Providence, Illumina (NASDAQ: ILMN), and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a cancer patient’s diagnosis, leads to ...

According to a new market research report titled, 'Whole Genome Sequencing Market Size, Share, Forecast, & Trends Analysis by ...

According to a new market research report titled, 'Whole Genome Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Library ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...